Cancer-Specific AI Applications

For Clinical & Research Use

We have licensed regulatory (CE-IVD & US-FDA) approved cancer-specific artificial intelligent applications (AI-apps)
for clinical and research purposes. These include:

Biopsy Tissues: Breast, Colon, Prostate, Metastasis Detection, Tumor Detection.

Cytopathology: Cervical cancer digital screening system.

Biomarkers: H&E, Hormone Receptor, Tissue Type

For Further Information:

Need More Information?

I’m Here To Assist You

Something isn’t Clear?
Feel free to contact me, and I will be more than happy to answer all of your questions.